UPSHER-SMITH 200 mg (Topiramate Extended-Release 200 mg)
Pill with imprint UPSHER-SMITH 200 mg is Brown / Gray, Capsule-shape and has been identified as Topiramate Extended-Release 200 mg. It is supplied by Upsher-Smith Laboratories, Inc.
Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; seizure prevention; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for UPSHER-SMITH 200 mg
- UPSHER-SMITH 200 mg
- 200 mg
- Brown / Gray
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Upsher-Smith Laboratories, Inc.
- Inactive Ingredients
hypromellose 2910 (6 mPa.s),
ethylcellulose (10 mPa.s),
ferric oxide red,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|00832-1073||Upsher-Smith Laboratories Inc.|
|00245-1073||Upsher-Smith Laboratories Inc.|
Related images for "UPSHER-SMITH 200 mg"
More about topiramate
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1,235)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Drug Information
- Topiramate (Advanced Reading)
- Topiramate Tablets
- Topiramate Extended-Release Capsules
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Sprinkle Capsules
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.